术前[18F]FDG-PET/CT对外阴癌淋巴结分期的诊断效能:一项大型单中心研究
该回顾性单中心研究纳入160例外阴癌患者,评估术前[18F]FDG-PET/CT预测腹股沟和盆腔淋巴结状态的诊断效能,以组织病理学为参考标准。结果显示,视觉评估、整体评估和半定量分析在腹股沟淋巴结水平均表现出良好的敏感性和阴性预测值,定性分析可作为可靠的解读标准。
要点
- 腹股沟淋巴结视觉评估敏感性85.6%、NPV 91.2%。
- 整体评估特异性78.2%,半定量分析特异性85.0%。
- 定性分析可靠,无需常规使用SUVmax等半定量方法。
核心结论
- 术前[18F]FDG-PET/CT在外阴癌淋巴结分期中表现出良好的敏感性和阴性预测值。
- 常规临床实践中,定性分析是可靠的解读标准,无需常规使用SUVmax等半定量方法。
研究设计与样本
- 所有患者均接受外阴和腹股沟股淋巴结手术,其中35例接受盆腔淋巴结手术。
- 以组织病理学为参考标准,计算预测腹股沟和盆腔淋巴结状态的敏感性、特异性、准确性、PPV和NPV。
主要发现
- 共338个淋巴结部位(296个腹股沟和42个盆腔)经组织学检查,转移性腹股沟和盆腔部位的患病率分别为30.4%和28.6%。
- 腹股沟水平视觉评估的敏感性、特异性、准确性、PPV和NPV分别为85.6%(78.3-92.8)、65.5%(59.0-72.0)、71.6%(66.5-76.8)、52.0%(44.0-60.1)和91.2%(86.7-95.8)。
- 腹股沟水平整体评估的敏感性、特异性、准确性、PPV和NPV分别为78.9%(70.5-87.3)、78.2%(72.5-83.8)、78.4%(73.7-83.1)、61.2%(52.3-70.1)和89.4%(85.0-93.9)。
- 腹股沟水平半定量分析(SUVmax截断值1.89,经ROC分析得出)的敏感性、特异性、准确性、PPV和NPV分别为73.3%(64.2-82.5)、85.0%(80.1-89.8)、81.4%(77.0-85.8)、68.0%(58.8-77.3)和87.9%(83.4-92.5)。
- 基于盆腔的分析观察到类似结果。
关键数值与推荐
- 视觉评估:敏感性85.6%(78.3-92.8),特异性65.5%(59.0-72.0),NPV 91.2%(86.7-95.8)。
- 整体评估:敏感性78.9%(70.5-87.3),特异性78.2%(72.5-83.8),NPV 89.4%(85.0-93.9)。
- 半定量分析:SUVmax截断值1.89,敏感性73.3%(64.2-82.5),特异性85.0%(80.1-89.8),NPV 87.9%(83.4-92.5)。
临床怎么用
- 术前[18F]FDG-PET/CT可用于外阴癌患者腹股沟和盆腔淋巴结转移的无创评估。
- 定性分析(视觉评估或整体评估)是可靠的解读方法,无需常规计算SUVmax。
局限性
- 回顾性单中心设计。
- 仅35例患者接受了盆腔淋巴结手术,盆腔分析样本量有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This retrospective study aimed to assess the diagnostic performance of preoperative [18F]FDG-PET/CT in predicting the groin and pelvic lymph node (LN) status in a large single-centre series of vulvar cancer patients. METHODS: Between January 2013 and October 2018, among all consecutive women with proven vulvar cancer submitted to [18F]FDG-PET/CT, 160 patients were included. LNs were analysed by two qualitative methods assessing PET information (defined as visual assessment) and a combination of PET and low-dose CT information (defined as overall assessment), respectively, as well as semi-quantitative analysis (LN-SUVmax). Sensitivity, specificity, accuracy, positive and negative predictive values (PPV and NPV) in predicting the groin and pelvic LN status were calculated in the overall study population; a subset analysis of groin parameters in clinically/ultrasonography negative patients was also performed. Histopathology was the reference standard. RESULTS: All patients underwent vulvar and inguinofemoral LN surgery, and 35 pelvic LN surgery. Overall, 338 LN sites (296 groins and 42 pelvic sites) were histologically examined with 30.4% prevalence of metastatic groins and 28.6% for metastatic pelvic sites. In the overall study population, sensitivity (95% confidence interval, CI), specificity (95% CI), accuracy (95% CI), PPV (95% CI) and NPV (95% CI) at the groin level were 85.6% (78.3-92.8), 65.5% (59.0-72.0), 71.6% (66.5-76.8), 52.0% (44.0-60.1) and 91.2% (86.7-95.8) for visual assessment; 78.9% (70.5-87.3), 78.2% (72.5-83.8), 78.4% (73.7-83.1), 61.2% (52.3-70.1) and 89.4% (85.0-93.9) for overall assessment; and 73.3% (64.2-82.5), 85.0% (80.1-89.8), 81.4% (77.0-85.8), 68.0% (58.8-77.3) and 87.9% (83.4-92.5) for semi-quantitative analysis (SUVmax cut-off value 1.89 achieved by ROC analysis). Similar results were observed in the pelvis-based analysis. CONCLUSION: In this large single-centre series of vulvar cancer patients, [18F]FDG-PET/CT showed good values of sensitivity and NPV in discriminating metastatic from non-metastatic LNs. In routine clinical practice, qualitative analysis is a reliable interpretative criterion making unnecessary commonly used semi-quantitative methods such as SUVmax.
引用
- Rufini V, Garganese G, Ieria FP, et al. Diagnostic performance of preoperative [18F]FDG-PET/CT for lymph node staging in vulvar cancer: a large single-centre study. Eur J Nucl Med Mol Imaging. 2021. PMID: 33619601. doi:10.1007/s00259-021-05257-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。